Skip to contentSkip to filters

We use cookies for analytics.

Grant, Call number PAR-25-374

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

National Institutes of Health

Related content

About

Investigators can assess whether approved or investigational medicines developed for other conditions could be repurposed for Alzheimer’s disease or related dementias. The grant also supports research on combinations predicted to affect disease mechanisms.

Topics

Eligibility

Covers: R01 support for preclinical research. Clinical trials are outside this call.

Eligible organizations based outside the US may apply.

simpler.grants.govgrants.nih.gov

Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.

Source: simpler.grants.gov